聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 36 分钟 5 秒 前

NeuroPhage Expands Series D Financing To $27 Million

周三, 01/14/2015 - 13:41
Funds Will Advance Breakthrough Drug Candidate NPT088 into the Clinic CAMBRIDGE, Mass., Jan. 14, 2015 -- (Healthcare Sales & Marketing Network) -- NeuroPhage Pharmaceuticals, Inc., today announced that it has closed $10.0 million from new investors in ...
Biopharmaceuticals, Neurology, Venture Capital
NeuroPhage Pharmaceuticals, NPT088, neurodegenerative

Tissue Regeneration Systems Adds Business Development Executive

周三, 01/14/2015 - 13:35
PLYMOUTH, Mich., Jan. 14, 2015 -- (Healthcare Sales & Marketing Network) -- Tissue Regeneration Systems, Inc. ("TRS") today announced that Sharon Schulzki has joined the company as Senior Vice President of Business Development. Prior to joining...
Devices, Personnel
Tissue Regeneration Systems

Teleflex Incorporated Highlights Article on ARROW(R) VPS(R) Vascular Positioning System, Showing Significant Reduction in Catheter Malpositions

周二, 01/13/2015 - 13:15
Article Shows Advantages of Using System that Replaces Chest X-Ray to Check Central IV Line Placement WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and sur...
Devices
Teleflex, ARROW VPS, ARROW, Vascular Positioning System

Teleflex Reports Study Results of ARROWg+ard(R) Technology Effectiveness in Preventing Infections and Associated Costs in an Infection-Prone Insertion Site

周二, 01/13/2015 - 13:09
Peer-Reviewed Published Research Reconfirms Clinical Benefits and Cost-Effectiveness of Chlorhexidine/Silver Sulfadiazine-Impregnated CVC WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medic...
Devices
Teleflex, ARROWg+ard, ARROW

Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products

周二, 01/13/2015 - 13:02
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust covering PICC (peripherally inserted central cathete...
Devices, Group Purchasing
Teleflex, HealthTrust, ARROW, PICC

ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer

周二, 01/13/2015 - 12:58
EDISON, N.J., Jan. 13, 2015 -- (Healthcare Sales & Marketing Network) -- ContraVir Pharmaceuticals, Inc. (CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today the appointment ...
Biopharmaceuticals, Personnel
ContraVir Pharmaceuticals

MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO

周一, 01/12/2015 - 16:59
Alfred Mann to Remain Focused on Development and Financing of Future Products of MannKind VALENCIA, Calif., Jan. 12, 2015 -- (Healthcare Sales & Marketing Network) -- MannKind Corporation (MNKD), a biopharmaceutical-based technology company, today annou...
Biopharmaceuticals, Personnel
MannKind

Debiopharm Group(TM) Regains Full Rights to Alisporivir Program

周一, 01/12/2015 - 12:44
Novartis returns Alisporivir (DEB025) to Debiopharm Group™ including all rights for HCV and other indications LAUSANNE, Switzerland, January 12, 2015 -- (Healthcare Sales & Marketing Network) -- Debiopharm Group™ (Debiopharm), a Swiss-based global biop...
Biopharmaceuticals
Debiopharm Group, Novartis, Alisporivir, Hepatitis C

CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases

周一, 01/12/2015 - 12:39
SEATTLE, Jan. 12, 2015 -- (Healthcare Sales & Marketing Network) -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) announced today the appointment of Alan K. Burnett, M.D., to serve as the strategic leader for myeloid development. Dr. Burnett ...
Biopharmaceuticals, Personnel
CTI BioPharma Corp

Micro Interventional Devices, Inc. Completes STASIS Clinical Trial Enrollment

周五, 01/09/2015 - 21:16
Permaseal meets primary clinical endpoints NEWTOWN, Pa., Jan. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Micro Interventional Devices, Inc. (MID) has completed enrollment in its Secure Transapical Access and Closure Study (STASIS). STASIS is...
Devices, Interventional Cardiology
Micro Interventional Devices, Permaseal, transcatheter, valve replacement

bioTheranostics Appoints Key Executives to Leadership Team

周五, 01/09/2015 - 21:06
SAN DIEGO--(Healthcare Sales & Marketing Network)--bioTheranostics, Inc., a leader in molecular diagnostics for cancer, today announced the addition of two industry veterans to its senior management team as the company focuses on further commercial expansi...
Diagnostics, Personalized Medicine, Oncology, Personnel
bioTheranostics, Breast Cancer Index

Endo Announces Changes to Senior Management Team

周五, 01/09/2015 - 21:01
Moves designed to accelerate Endo's continued evolution into a leading global specialty healthcare company Changes to reporting structure will support Endo's future growth DUBLIN, Jan. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Endo Intern...
Biopharmaceuticals, Personnel
Endo International

Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations

周五, 01/09/2015 - 20:56
SANTA MONICA, Calif., Jan. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Kite Pharma, Inc., (KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer...
Biopharmaceuticals, Oncology, Personnel
Kite Pharma, immunotherapy, chimeric antigen receptor

Straub Medical AG obtains approval for Rotarex(R)S and Aspirex(R)S endovascular catheters in China

周四, 01/08/2015 - 13:32
Chinese FDA approves Straub Endovascular System Wangs, Switzerland, (Healthcare Sales & Marketing Network) - Straub Medical AG announced today that the Chinese FDA has approved the Straub Endovascular System with its Rotarex®S and Aspirex®S rota...
Devices, Interventional, Regulatory
Straub Medical AG, Straub Endovascular, RotarexS, AspirexS, rotational catheters

Vascular Dynamics Inc. Secures $16.85 Million Series B Financing

周四, 01/08/2015 - 13:17
The Funding Will Be Used to Advance the Company's Program for the Treatment of Resistant Hypertension MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Vascular Dynamics Inc. (VDI) a medical device company providing minimally invasive solution...
Devices, Venture Capital
Vascular Dynamics, resistant hypertension, MobiusHD, CALM-FIM

Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors

周四, 01/08/2015 - 13:06
Identifies Up to 44 Percent More Eligible Patients Than Conventional BRCA Tests SALT LAKE CITY and ZURICH, Jan. 8, 2015 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today announced the Company has obtained CE Marking in Euro...
Diagnostics, Oncology, Regulatory
Myriad Genetics, BRACAnalysis CDx, BRCA1, BRCA2, Lynparza, PARP

Philips receives FDA 510(k) clearance for its latest Avalon CL Fetal Monitoring solution

周三, 01/07/2015 - 13:14
Advanced cableless solution detects fetal heart rate and maternal pulse allowing beneficial freedom of movement during labor ANDOVER, Mass., Jan. 7, 2015 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG AEX: PHIA) today announced ...
Devices, Monitoring, FDA
Royal Philips, Avalon CL, Fetal Monitoring

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin(TM) Platform for Cancer Therapeutics

周三, 01/07/2015 - 13:07
Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--Blend Therapeutics, Inc., a biopharmaceu...
Biopharmaceuticals, Oncology, Venture Capital
Blend Therapeutics, Pentarin , miniaturized biologic drug conjugates

AVEO Announces Executive Transition and Corporate Restructuring

周三, 01/07/2015 - 13:01
Michael P. Bailey Named President and Chief Executive Officer; Tuan Ha-Ngoc Named Chairman of the Board Company to Eliminate Internal Research Function to Align Corporate Resources with the Company’s Future Strategic Plans CAMBRIDGE, Mass.--(Healthc...
Biopharmaceuticals, Oncology, Personnel
AVEO Oncology

Mundipharma receives positive European Commission decision on Targin(R) (oxycodone/naloxone) for the treatment of Restless Legs Syndrome1

周三, 01/07/2015 - 12:53
CAMBRIDGE, England--(Healthcare Sales & Marketing Network)--Mundipharma today announced that Targin® (Targinact®, Targiniq®), a fixed combination of prolonged-release oxycodone/naloxone, has received a positive European Commission decision for ...
Biopharmaceuticals, Regulatory
Mundipharma, Targin, Targinact, Targiniq, restless legs syndrome

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong